Test Interpretation and Errors

2009 ◽  
pp. 401-401-15
Author(s):  
HB Seed ◽  
JK Mitchell
Keyword(s):  
2020 ◽  
pp. jclinpath-2020-207103
Author(s):  
Lisa Senzel ◽  
Tahmeena Ahmed ◽  
Rebecca Batiste

COVID-19 arrived at our medical centre in March 2020 with substantial force. Clinical pathology concepts began to have a new, direct relevance to our residents’ lives. As we wondered ‘Have I been exposed? Do I need to self-isolate? Are the tests reliable? Am I protecting myself adequately while handling specimens?’, these questions drew new interest in laboratory methods, test interpretation and limitations, supply chain issues, safety and quality. By incorporating SARS-CoV-2 teaching points into laboratory medicine lectures, we enlivened concepts of sensitivity, specificity, predictive value and methodologic issues in serologic, molecular and antigen testing for pathology residents. We drew from the emerging literature on SARS-CoV-2 to create lectures and added details from our own institutional experience with COVID-19. When the pandemic fades from memory, clinical pathology education can still benefit from mnemonics, analogies, anecdotes and creative efforts that capture the attention of the audience.


Author(s):  
Simon Thompson ◽  
Mary Kathryn Bohn ◽  
Nicasio Mancini ◽  
Tze Ping Loh ◽  
Cheng-Bin Wang ◽  
...  

AbstractRoutine biochemical and hematological tests have been reported to be useful in the stratification and prognostication of pediatric and adult patients with diagnosed coronavirus disease (COVID-19), correlating with poor outcomes such as the need for mechanical ventilation or intensive care, progression to multisystem organ failure, and/or death. While these tests are already well established in most clinical laboratories, there is still debate regarding their clinical value in the management of COVID-19, particularly in pediatrics, as well as the value of composite clinical risk scores in COVID-19 prognostication. This document by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 provides interim guidance on: (A) clinical indications for testing, (B) recommendations for test selection and interpretation, (C) considerations in test interpretation, and (D) current limitations of biochemical/hematological monitoring of COVID-19 patients. These evidence-based recommendations will provide practical guidance to clinical laboratories worldwide, underscoring the contribution of biochemical and hematological testing to our collective pandemic response.


2016 ◽  
Vol 19 (5) ◽  
pp. 575-582 ◽  
Author(s):  
Julianne M. O’Daniel ◽  
Heather M. McLaughlin ◽  
Laura M. Amendola ◽  
Sherri J. Bale ◽  
Jonathan S. Berg ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (4) ◽  
pp. e34708 ◽  
Author(s):  
Michelle Bronze ◽  
Kim Steegen ◽  
Carole L. Wallis ◽  
Hans De Wolf ◽  
Maria A. Papathanasopoulos ◽  
...  

1995 ◽  
Vol 4 (3) ◽  
pp. 5-8 ◽  
Author(s):  
Alison Garton

This paper is concerned with ethical issues in the practice and administration of tests. Some broad principles related to the knowledge required for test usage are described, together with the skills necessary for competent test use. Ethical practice in relation to test users, training in testing, test administration, test interpretation and test instruments is also examined. The focus then changes to a consideration of the more general ethical principles that apply to professional practice and are equally applicable to testing. A final section examines the relevance of these issues for career guidance practitioners and also some recent professional developments that will encourage ethical practice in testing.


Sign in / Sign up

Export Citation Format

Share Document